Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-17 @ 2:36 PM
Study NCT ID:
NCT05136456
Status:
UNKNOWN
Last Update Posted:
2023-09-05
First Post:
2021-11-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy
Sponsor:
Reistone Biopharma Company Limited
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Primary Membranous Nephropathy | View |
Keywords: